Alkermes plc. Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent
Alkermes plc. (ALKS) reported Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent of 0.90% for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-25.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance · last filed 2026-02-25
- Alkermes plc. effective income tax rate reconciliation, change in deferred tax assets valuation allowance, percent for fiscal 2025 was 0.90%.
- Alkermes plc. effective income tax rate reconciliation, change in deferred tax assets valuation allowance, percent for fiscal 2024 was -0.40%.
- Alkermes plc. effective income tax rate reconciliation, change in deferred tax assets valuation allowance, percent for fiscal 2023 was -37.80%.
- Alkermes plc. effective income tax rate reconciliation, change in deferred tax assets valuation allowance, percent for fiscal 2014 was -79.50%.
| Period end | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent 9 month | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent 9 month as first filed | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent 12 month | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent 12 month as first filed |
|---|---|---|---|---|
| 2025-12-31 | 0.90% 10-K · filed 2026-02-25 | |||
| 2024-12-31 | -0.40% 10-K · filed 2026-02-25 | |||
| 2023-12-31 | -37.80% 10-K · filed 2026-02-25 | |||
| 2014-12-31 | -79.50% 10-K · filed 2015-02-24 | |||
| 2013-12-31 | -321.00% 10-K · filed 2015-02-24 | -321.40% 10-KT · filed 2014-02-27 | ||
| 2013-03-31 | -7.50% 10-K · filed 2015-02-24 | -28.00% 10-K · filed 2013-05-23 | ||
| 2012-03-31 | 55.70% 10-KT · filed 2014-02-27 | 47.30% 10-K · filed 2012-05-18 | ||
| 2011-03-31 | -30.10% 10-K · filed 2013-05-23 | |||
| 2010-03-31 | -19.90% 10-K · filed 2012-05-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |